Abstract
OBJECTIVE—To establish national clinical guidelines and integrated care pathways for five conditions (tuberous sclerosis (TS), Huntington's disease (HD), myotonic dystrophy (MD), neurofibromatosis type 1 (NF1), and Marfan syndrome (MS)) and audit their use in Scotland. DESIGN—Systematic review of published reports followed by consensus conferences to prepare clinical guidelines and integrated care pathways. Structured review of medical records before and after introduction of integrated care pathways to document changes in practice. Survey of staff views on procedures adopted. SETTING—All four clinical genetics centres in Scotland. RESULTS—Project resulted in reduced variation in practice across centres, improved data recording in medical records, and improved communication with other professional groups. A very poor evidence base for management of patients with the conditions studied was found. CONCLUSIONS—A collaborative structure for undertaking clinical research would improve the evidence base for current practice. National discussion of the boundaries of responsibility of care for the long term management of patients with these disorders is required. The integrated care pathway approach shows promise as a means of facilitating the development of audit within clinical genetics services. Keywords: clinical guidelines; audit; evidence based medicine; care pathways
Full Text
The Full Text of this article is available as a PDF (121.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bradshaw N., Brewer C., FitzPatrick D., Murray G., Rodgers F., Porteous M., Campbell H. Guidelines and care pathways for genetic diseases: the Scottish collaborative project on tuberous sclerosis. Eur J Hum Genet. 1998 Sep-Oct;6(5):445–458. doi: 10.1038/sj.ejhg.5200208. [DOI] [PubMed] [Google Scholar]
- Campbell H., Hotchkiss R., Bradshaw N., Porteous M. Integrated care pathways. BMJ. 1998 Jan 10;316(7125):133–137. doi: 10.1136/bmj.316.7125.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Clarke A., Parsons E., Williams A. Outcomes and process in genetic counselling. Clin Genet. 1996 Dec;50(6):462–469. doi: 10.1111/j.1399-0004.1996.tb02713.x. [DOI] [PubMed] [Google Scholar]
- Ferguson J. H. The NIH Consensus Development Program. The evolution of guidelines. Int J Technol Assess Health Care. 1996 Summer;12(3):460–474. [PubMed] [Google Scholar]
- Gutmann D. H., Aylsworth A., Carey J. C., Korf B., Marks J., Pyeritz R. E., Rubenstein A., Viskochil D. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA. 1997 Jul 2;278(1):51–57. [PubMed] [Google Scholar]
- Harris R., Harris H. Clinical governance and genetic medicine. Specialist genetic centres and the Confidential Enquiry into Counselling for Genetic Disorders by non-geneticists (CEGEN) J Med Genet. 1999 Apr;36(4):350–351. [PMC free article] [PubMed] [Google Scholar]
- Harris R. How well do we manage families with genetic problems? BMJ. 1991 Dec 7;303(6815):1412–1413. doi: 10.1136/bmj.303.6815.1412. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harris R., Lane B., Harris H., Williamson P., Dodge J., Modell B., Ponder B., Rodeck C., Alberman E. National Confidential Enquiry into counselling for genetic disorders by non-geneticists: general recommendations and specific standards for improving care. Br J Obstet Gynaecol. 1999 Jul;106(7):658–663. doi: 10.1111/j.1471-0528.1999.tb08364.x. [DOI] [PubMed] [Google Scholar]
- Lilford R. J., Thornton J. G., Braunholtz D. Clinical trials and rare diseases: a way out of a conundrum. BMJ. 1995 Dec 16;311(7020):1621–1625. doi: 10.1136/bmj.311.7020.1621. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lomas J. Words without action? The production, dissemination, and impact of consensus recommendations. Annu Rev Public Health. 1991;12:41–65. doi: 10.1146/annurev.pu.12.050191.000353. [DOI] [PubMed] [Google Scholar]
- Murphy M. K., Black N. A., Lamping D. L., McKee C. M., Sanderson C. F., Askham J., Marteau T. Consensus development methods, and their use in clinical guideline development. Health Technol Assess. 1998;2(3):i-iv, 1-88. [PubMed] [Google Scholar]
- Petrie J. C., Grimshaw J. M., Bryson A. The Scottish Intercollegiate Guidelines Network Initiative: getting validated guidelines into local practice. Health Bull (Edinb) 1995 Nov;53(6):345–348. [PubMed] [Google Scholar]